Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Japan IVD Point-of-Care Testing Market Set for Growth Through 2030, Driven by Rapid Diagnostics Innovation and Expanding Decentralized Care

globenewswire.com
ABT Abbott Laboratories is mentioned as a global diagnostics company competing in the Japan IVD point-of-care testing market, which is projected for growth. The article does not provide specific performance details for Abbott. BDX Becton Dickinson is listed as an international supplier and competitor in the Japan IVD point-of-care testing market. The article highlights the market's growth potential but offers no specific sentiment towards Becton Dickinson's performance. DHR Danaher (through its Radiometer division) is identified as a competitor in the Japan IVD point-of-care testing market. The article discusses the overall market growth but does not provide specific sentiment for Danaher. TER Terumo is named as a domestic manufacturer and competitor in the Japan IVD point-of-care testing market. The article anticipates growth in this sector, but no specific sentiment is directed towards Terumo.

Japan IVD Point-of-Care Testing Market Set for Growth Through 2030, Driven by Rapid Diagnostics Innovation and Expanding Decentralized Care Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) -- "Japan IVD Point of Care Testing Market, Key Company Profiles, Market Dynamics and Recent Developments - Forecast to 2030" has been added to ResearchAndMarkets.com's offering.

The Japan IVD Point-of-Care (POC) Testing Market is projected to surpass US$700 million by 2030, rising from approximately US$450 million in 2025. Japan remains one of the largest and most technologically advanced point-of-care diagnostics markets in the Asia-Pacific region, supported by its rapidly aging population, growing incidence of chronic and infectious diseases, universal health insurance system and established healthcare infrastructure.

Demand for point-of-care testing in Japan continues to increase across hospitals, emergency departments, outpatient clinics, pharmacies, nursing homes and home healthcare environments. The market is benefiting from healthcare providers' focus on faster test results, decentralized diagnostic services and timely clinical decision-making. Blood glucose monitoring, HbA1c testing, blood gas and electrolyte analysis, cardiac biomarkers, urinalysis, infectious disease diagnostics and critical care testing are among the principal areas of adoption.

Japan's expanding home healthcare and community-based medical services are creating additional opportunities for portable and connected diagnostic platforms. These systems are increasingly used to support elderly patient care and the long-term management of diabetes, cardiovascular disease, kidney disease and other chronic conditions. Integration with laboratory information systems, electronic medical records and digital health platforms is also strengthening workflow efficiency, data accessibility and clinical coordination.

Japan IVD Point-of-Care Testing Market Segment Highlights

Recent Point-of-Care Diagnostics Developments

Competitive Landscape

Competition in the Japan IVD point-of-care testing market includes established domestic manufacturers and global diagnostics companies. ARKRAY, Fujifilm, Terumo, Denka, Eiken Chemical, Fujirebio, Fukuda Denshi, Sysmex and TAUNS compete alongside Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher-Radiometer, Becton Dickinson and other international suppliers. Market participants continue to invest in molecular diagnostics, connected instruments, assay development, automation and portable testing technologies.

Report Coverage

The report, "Japan IVD Point of Care (POC) Testing Market-By Segment, Key Company Profiles, Market Dynamics and Recent Developments-Forecast to 2030," provides market size, share and forecast analysis for 2021 through 2030. It evaluates nine principal segments: POC cardiac testing; blood gas and electrolytes; urinalysis; hospital glucose testing connected to laboratory information systems; chemistry and HbA1c; patient monitoring and coagulation; infectious diseases; critical care; and other POC applications.

Cardiac testing coverage includes troponin, BNP, pro-BNP and other cardiac biomarkers. Infectious disease analysis includes HIV, sexually transmitted diseases, hepatitis, vector-borne diseases, gastrointestinal infections and respiratory infections. The critical care assessment covers CRP and PCT testing, while the chemistry category includes both general POC chemistry and HbA1c testing.

The competitive analysis profiles Denka, Roche, Danaher-Radiometer, D.S. Pharma, Siemens Healthineers, Becton Dickinson, Techno Medica, Eiken Chemical, Fujifilm, FUJIFILM Wako, Fujirebio, Fukuda Denshi, LSI Medience, Sekisui, Abbott, Werfen, Horiba, ARKRAY, Terumo, Nipro, Nihon Kohden, TAUNS, Sysmex-related market developments and other diagnostic technology providers active in Japan.

With sustained investment in healthcare digitization, molecular testing, chronic disease management and decentralized care, the Japan IVD point-of-care testing market is positioned for continued expansion through 2030. Rapid infectious disease diagnostics, critical care testing and connected platforms are expected to remain central to future market growth.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

2.1 Research Design

2.2 Research Approach

2.3 Data Collection Methods

2.4 Market Assumptions

3. Japan IVD Point of Care (POC) Testing Market and Forecast (2021-2030)

3.1 By Segment - Japan IVD Point of Care (POC) Testing Market Share & Forecast

3.2 By Company - Japan IVD Point of Care (POC) Testing Market Share & Forecast

4. Japan - POC Cardiac Market & Forecast (2021-2030)

4.1 By Company - Japan POC Cardiac Market Revenue & Forecast

4.2 Japan - Troponin Market & Forecast

4.2.1 By Company - Japan Troponin Market Revenue & Forecast

4.3 Japan - BNP Market & Forecast

4.3.1 By Company - Japan BNP Market Revenue & Forecast

4.4 Japan - Pro-BNP Market & Forecast

4.4.1 By Company - Japan Pro-BNP Market Revenue & Forecast

4.5 Japan - Other POC Cardiac Market & Forecast

4.5.1 By Company - Japan Other POC Cardiac Market Revenue & Forecast

5. Japan - POC Bloodgas & Electrolytes Market & Forecast (2021-2030)

5.1 By Company - Japan POC Bloodgas & Electrolytes Market Revenue & Forecast

6. Japan - POC Urinalysis Market & Forecast (2021-2030)

6.1 By Company - Japan POC Urinalysis Market Revenue & Forecast

7. Japan - POC Hospital Glucose (connected to LIS) Market & Forecast (2021-2030)

7.1 By Company - Japan POC Hospital Glucose (connected to LIS) Market Revenue & Forecast

8. Japan - POC Chemistry + HbA1c Market & Forecast (2021-2030)

8.1 By Company - Japan POC Chemistry + HbA1c Market Revenue & Forecast

8.2 Japan - POC Chemistry Market & Forecast

8.2.1 By Company - Japan POC Chemistry Market Revenue & Forecast

8.3 Japan - POC HbA1c Market & Forecast

8.3.1 By Company - Japan POC HbA1c Market Revenue & Forecast

9. Japan - POC Patient Monitoring / Coagulation Market & Forecast (2021-2030)

9.1 By Company - Japan POC Patient Monitoring / Coagulation Market Revenue & Forecast

10. Japan - POC Infectious Diseases Market & Forecast (2021-2030)

10.1 By Company - Japan POC Infectious Diseases Market Revenue & Forecast

10.2 Japan - HIV Market & Forecast

10.2.1 By Company - Japan HIV Market Revenue & Forecast

10.3 Japan - STD Market & Forecast

10.3.1 By Company - Japan STD Market Revenue & Forecast

10.4 Japan - Hepatitis Market & Forecast

10.4.1 By Company - Japan Hepatitis Market Revenue & Forecast

10.5 Japan - VBD Market & Forecast

10.5.1 By Company - Japan VBD Market Revenue & Forecast

10.6 Japan - Gastrointestinal Market & Forecast

10.6.1 By Company - Japan Gastrointestinal Market Revenue & Forecast

10.7 Japan - Respiratory Market & Forecast

10.7.1 By Company - Japan Respiratory Market Revenue & Forecast

11. Japan - POC Critical Care Market & Forecast (2021-2030)

11.1 By Company - Japan POC Critical Care Market Revenue & Forecast

11.2 Japan - CRP Market & Forecast

11.2.1 By Company - Japan CRP Market Revenue & Forecast

11.3 Japan - PCT Market & Forecast

11.3.1 By Company - Japan PCT Market Revenue & Forecast

12. Japan - POC Others Market & Forecast (2021-2030)

12.1 By Company - Japan POC Others Market Revenue & Forecast

12.2 Japan - Pregnancy Market & Forecast

12.2.1 By Company - Japan Pregnancy Market Revenue & Forecast

13. Japan IVD Point of Care (POC) Testing Market - Recent Developments

14. Japan IVD Point of Care (POC) Testing Market - Key Company Profiles, IVD POCT Revenue

14.1 Denka

14.2 Roche

14.3 Danaher - Radiometer

14.4 D.S. Pharma

14.5 Siemens

14.6 Becton Dickinson

14.7 Techno Medica

14.8 EIKEN CHEMICAL

14.9 Fujifilm

14.10 Fujifilm - Wako

14.11 Fujirebio

14.12 Fukuda Denshi

14.13 LSI Medience

14.14 Sekisui

14.15 Abbott

14.16 Werfen - Instrumentation Laboratory

14.17 Horiba ABX - Horiba

14.18 Arkray

14.19 Sanwa

14.20 Terumo

14.21 Nipro

14.22 Nihon Kohden

14.23 Nissui

14.24 Minaris

14.25 Mizuho

14.26 Toyobo

14.27 SD Biosensor

14.28 Nova Biomedical

14.29 Alfresa Pharma

14.30 TAUNS

14.31 Nippon Gene

14.32 Otsuka

15. Japan IVD Point of Care (POC) Testing - Market Dynamics

15.1 Japan IVD Point of Care (POC) Testing Market - Drivers

15.2 Japan IVD Point of Care (POC) Testing Market - Challenges

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/xmymhn

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.